Insights into Sickle Cell Disease: Complexities of Care

Program Description
Patients with sickle cell disease (SCD) experience increased rates of emergency department visits and hospitalizations due to vaso-occlusive events. Patients experience chronic and episodic pain but acute pain crises due to vaso-occlusion can affect multiple organ systems and may result in increased disability or early mortality and reduced quality of life. While increased newborn and prenatal screening for SCD has improved the life expectancy, optimal management of this lifelong illness is multifaceted and requires a patient-centered approach. Pharmacists and managed care professionals can have significant impact in providing quality care by facilitating access to treatment and helping overcome treatment challenges. New and emerging pharmacologic therapies present potential benefits for patients with SCD, and managed care professionals need to be prepared to incorporate these newer agents into the treatment landscape for SCD.

Target Audience: Managed care pharmacists

Type of Activity: Application

Release date: November 1, 2021
Expiration date: November 1, 2022

Time to complete activity: 1.5 hours

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Document the pathophysiology of sickle cell disease and the treatment challenges associated with the management of the disease and its comorbidities.
• Differentiate the various pharmacotherapeutic options and treatment strategies for SCD including recent clinical and real-world data.
• Explain the health-related quality of life and economic burden of SCD and evaluate the various therapies for appropriate utilization.

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-21-376-H01-P. The activity is available for CE credit through November 1, 2022.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Lindsey E. Dayer, PharmD, BCACP, and Susan Trieu, PharmD

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Rose Namissa, PharmD, BCPS; Liz Rauh; Susan Pordon; Brianna Winters; and Chloe Taccetta

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms